Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

News SummaryMost relevantAll newsSector news 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
05/10/2012 | 08:13am CEST
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on TERUMO CORP
10/20 ST JUDE MEDICAL : Abbott to Sell Portion of Vascular Closure, Electrophysiology ..
10/20 Terumo to buy U.S. vascular closure device businesses for $1.1 billion
10/20 TERUMO : Sources Sought Notice - J-- Terumo APS system contract
10/19 ST. JUDE MEDICAL, INC. (NYSE : STJ) Files An 8-K
10/18 Terumo to buy some U.S. firms' businesses for $1.12 bil.
10/18 Abbott and St. Jude to sell products to Terumo
10/18 TERUMO : to Acquire Portion of Vascular Closure Portfolio and Other Assets of St..
09/28 TERUMO : MicroVention Assigned Patent
09/28 TERUMO CORP : ex-dividend day for interim dividend
09/14 TERUMO : Federal Contracts Awarded by Federal Agencies in Massachusetts (Sept. 1..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/19DJST JUDE MEDICAL : Sales Rise 12% -- Update
10/19DJAbbott Labs Swings to Loss After Booking Charge on Mylan Stake
10/18DJST JUDE MEDICAL : Forms Cybersecurity Advisory Group
10/14 Private equity firms line up bids for BSN Medical - sources
10/11DJST JUDE MEDICAL : Warns of Battery Problems With Heart Products -- 3rd Update
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
10/19 Abbott's Vascular Tech Is Big In Japan
10/18 Abbott and St. Jude to jettison vascular closure products to Terumo for $1.1B
Financials ( JPY)
Sales 2017 509 027 M
EBIT 2017 -
Net income 2017 51 853 M
Debt 2017 31 288 M
Yield 2017 1,02%
P/E ratio 2017 29,04
P/E ratio 2018 26,50
EV / Sales 2017 3,10x
EV / Sales 2018 2,88x
Capitalization 1 545 625 M
More Financials
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 16
Average target price 4 410  JPY
Spread / Average Target 8,4%
Consensus details
EPS Revisions
More Estimates Revisions
Yutaro Shintaku President & Representative Director
Ryo Nishihata Chief Accounting & Financial Officer, IR Contact
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Takayoshi Mimura Director & Senior Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP9.70%14 798
MEDTRONIC PLC8.29%115 115
C R BARD INC15.56%16 081
More Results